
‘Double decker’ antibody technology fights cancer
Scientists from The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates…
Scientists from The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates…
Early findings from a first-in-human clinical trial showed that antibody drug conjugate (ADC) rovalpituzumab tesirine…